Literature DB >> 26442945

Erotomania and Recommendations for Treatment.

Mary V Seeman1.   

Abstract

The aim of this paper is to help clinicians better understand how erotomania originates in order to facilitate treatment and make it more effective. Data sources are the narratives of six women who spoke in detail about the beginnings of their delusional beliefs and about the nature of the evidence that convinced them that their beliefs were well-founded. In every case, low self-esteem and emotional arousal preceded the emergence of the delusion. Misperceptions and misattributions appeared responsible for keeping the delusion alive. Despite external disconfirmation, social isolation protected the delusional beliefs from revision and extinction. The erotomanic delusion provided a sense of well-being that probably contributed to its maintenance. As well, a delusion-induced boost in well-being delayed help-seeking. Recommendations for treatment include staged interventions, first establishing a therapeutic alliance with a focus on understanding the psychological factors contributing to the origin and maintenance of the delusion. The next stage is the provision of social support and strategies directed at the restoration of self-esteem. The third stage is the gradual introduction of techniques to correct cognitive biases. Medication and risk management form an integral part of overall management. Objective evidence for the effectiveness of this approach is, however, not yet available.

Entities:  

Keywords:  Cognitive biases; Erotomania; de Clérambault’s syndrome

Mesh:

Year:  2016        PMID: 26442945     DOI: 10.1007/s11126-015-9392-0

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  36 in total

1.  Delusional transference.

Authors:  V B HAMMETT
Journal:  Am J Psychother       Date:  1961-10

2.  Delusional ideation and self-esteem in individuals with psychotic disorders.

Authors:  Debbie M Warman; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2011-01       Impact factor: 2.254

3.  Assessing metacognition in schizophrenia with the Metacognition Assessment Scale: associations with the Social Cognition and Object Relations Scale.

Authors:  Paul H Lysaker; Giancarlo Dimaggio; Phoebe Daroyanni; Kelly D Buck; Valerie A LaRocco; Antonino Carcione; Giuseppe Nicolò
Journal:  Psychol Psychother       Date:  2010-02-18       Impact factor: 3.915

4.  The interpersonal world of psychosis.

Authors:  Matthew Ratcliffe
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

5.  The search for Cupid or the phantom-lover syndrome.

Authors:  M V Seeman
Journal:  Can Psychiatr Assoc J       Date:  1971-04

Review 6.  Erotomania : epidemiology and management.

Authors:  Brendan D Kelly
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Patients who stalk doctors: their motives and management.

Authors:  Michele T Pathé; Paul E Mullen; Rosemary Purcell
Journal:  Med J Aust       Date:  2002-04-01       Impact factor: 7.738

8.  It's no accident: Our bias for intentional explanations.

Authors:  Evelyn Rosset
Journal:  Cognition       Date:  2008-08-09

9.  Why do people with delusions fail to choose more realistic explanations for their experiences? An empirical investigation.

Authors:  Daniel Freeman; Philippa A Garety; David Fowler; Elizabeth Kuipers; Paul E Bebbington; Graham Dunn
Journal:  J Consult Clin Psychol       Date:  2004-08

10.  Jumping to the wrong conclusions? An investigation of the mechanisms of reasoning errors in delusions.

Authors:  Suzanne Jolley; Claire Thompson; James Hurley; Evelina Medin; Lucy Butler; Paul Bebbington; Graham Dunn; Daniel Freeman; David Fowler; Elizabeth Kuipers; Philippa Garety
Journal:  Psychiatry Res       Date:  2014-06-04       Impact factor: 3.222

View more
  1 in total

1.  De Clérambault's syndrome revisited: a case report of Erotomania in a male.

Authors:  Maria Teresa Tavares Rodrigues Tomaz Valadas; Lucilia Eduarda Abrantes Bravo
Journal:  BMC Psychiatry       Date:  2020-10-23       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.